The Technion researchers' study describes an evolutionary scenario where protection arises from a reduced level of tRNA (transfer RNA), a molecule critical for gene translation. "Studies on ...
Blinded baseline demographics and disease characteristics for ongoing Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary ...
The completion of chromosome synXVI allows scientists to explore new possibilities in metabolic engineering and strain ...
Macquarie University researchers have worked with an international team of scientists to achieve a major milestone in ...
Learn more about whether Natera, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on AAII's A+ ...
This study details the design and optimization of synXVI, a synthetic yeast chromosome, overcoming growth challenges through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback